The product quickly delivers oxygen into tissue and organs and buys time for the dog's own regenerative red blood cells to come back. Oxyglobin is created by using purified hemoglobin molecules derived from cow's blood. Hemoglobin in red blood cells delivers oxygen throughout the body, but anemia results if the number of red cells is reduced, as often happens during trauma, starving bodily tissues of oxygen. This potentially life-threatening condition often goes untreated in dogs. Because Oxyglobin is easily accessible, it will give every veterinarian the ability to treat anemic dogs quickly, effectively and safely.
Oxygen therapeutics offer key advantages over donated human or canine blood.
The company also has similar blood substitute products for humans that are in advanced clinical trials in the United States and Europe. Researchers in government and the private sector have been working to develop a blood substitute for use in humans for more than 50 years. Efforts intensified in the early 1980s with the advent of AIDS and the risk of transmitting HIV and other infectious diseases, such as hepatitis, via donated blood.